However, ERGAL silencing dramatically down-regulated the gene and protein expression of VE-cadherin and claudin-5, leading to intercellular gap formation, as well as disruptions in the cytoskeletal structure, all of which resulted in the imperfection and instability of vascular endothelial barrier during early infection. This evidence concerns the gene CDH5 and infection.